Skip to main content

Important updates and special communications about your Plan Vital

  • Important information about inclusion of Sofosbuvir/Velpatasvir (Epclusa Genérico) en PDL

    Normative Letter 24-0808

  • Important information regarding the implementation of drugs in the sub formulary for HIV/AIDS

    Normative Letter 24-0624B

  • Important information regarding the termination of a pharmacy of the Plan Vital network:

    ABC Pharmacy, Inc – San Juan

    Letter 24-0625

  • Important information regarding changes to the Preferred Drug List (PDL)

    Normative Letter 24-0531

  • Important information regarding the removal of pharmacies from the Plan Vital network due to closing:

    Farmacia Estrella 1- Ciales

    Circular Letter 24-0603

  • Important information regarding the discontinuation of Repatha Pushtronex

    Normative Letter 24-0501

  • Important information regarding the closing of pharmacy of the Plan Vital network:

    Farmacia Valle Tolima – Caguas

    Circular Letter 24-0422

  • Important information regarding the closing of pharmacy of the Plan Vital network:

    Farmacia San Pablo – Bayamón

    Circular Letter 24-0528

  • Important information regarding the removal of pharmacies from the Plan Vital network:

    Farmacia la Casa del Pensionado – San Juan

    Circular Letter 24-0513

  • Important information regarding the removal of pharmacies from the Plan Vital network:

    Farmacia San José – Aibonito

    Circular Letter 24-0506

  • Important information regarding changes to the Preferred Drug List (PDL)

    Circular Letter 24-0402

  • Important information regarding the removal of pharmacies from the Plan Vital network:

    Farmacia Nueva – Vega Alta

    Circular Letter 24-0402

  • Important information regarding the removal of pharmacies from the Plan Vital network:

    Farmacia HIMA San Pablo – Caguas
    Smart Care Pharmacy – Caguas

    Circular Letter 24-0312

  • Important information regarding changes to the Plan Vital pharmacy network:

    Reactivation: Farmacia del Carmen in Barceloneta

    Circular Letter 24-0213

  • Important information regarding changes to the Plan Vital pharmacy network:

    Temporary Removal: Multi-Farma in Barranquitas
    Voluntary ClosureL Farmacia Nueva in Carolina and Farmacia Plaza 3 in Bayamón

    Circular Letter 24-0209

  • Important information regarding the discontinuation of Flovent

    Download Letter in PDF

  • Important information regarding the removal of pharmacies from the Plan Vital network

    Farmacia Candelaria – Mayagüez
    One Stop Shop Prescription Puerto Rico, Inc – Santurce

    Download Letter in PDF

  • Important information regarding the temporary removal of pharmacies from the Plan Vital network:

    Farmacia del Carmen – Barceloneta
    Farmacia Jireh – Caguas

    Circular Letter 23-1227

  • Important information regarding the closing of pharmacies:

    Farmacia Laurel

    Circular Letter 23-1011

  • Important information regarding the closing of pharmacies:

    Farmacia La Sagrada Familia

    Circular Letter 23-1023

  • Important information regarding the closing of pharmacies:

    Farmacia Alborada
    Farmacia Grito de Lares

    Circular Letter 23-0928

  • Important information regarding the closing of pharmacies:

    Farmacia Tres Hermanos – Añasco
    Shaddai Pharmacy – Humacao

    Circular Letter 23-0907

  • Important information regarding the closing:

    Pharmamed del Norte

    Circular Letter 23-0807

  • Important information regarding the closing of Farmacia Plaza 4

  • Important information regarding pharmacy terminations:

    Farmacia Tañon
    Farmacia Wilmet

    Circular Letter 23-0608

  • Important information regarding pharmacy terminations:

    Farmacia Hospital San Cristóbal
    Farmacia Gabriela
    Farmacia Gabriela 1
    Farmacia Gabriela 2

    Download letters in PDF

    Circular Letter 23-0404 | Circular Letter 23-0420

  • Normative Letter 23-0427

    Shortage of several oncology drugs.

    Download Letter in PDF | File weight: 53 kb

  • What you should know about the recertification process

    A recertification is the process of reviewing or updating the evidence of the beneficiaries, who already have the benefit of the Vital Plan and Medicare Platino.

    Download the brochure in PDF | File weight: 1.5mb

  • Countersignature Rules and Medical Specialty

    Plan Vital Beneficiary. Don’t forget that, as part of your coordinated care, it is important that your PCP or a doctor within your Primary Medical Group countersigned the pharmacy medication prescription you receive from your specialist physicians. Check with your pharmacy that your refills comply with this requirement to avoid any setbacks with your treatment. If you have any questions call our Triple-S Vital Call Center at 1.800.981.1352 (TTY 1.855.295.4040) from 7am to 7pm seven days a week.

  • Normative Letter 22-1021-1

    Important Plan Vital information regarding new contract dates, changes period and transition period.

    Download the guide in PDF | File weight: 333 KB

  • If the drugstore does not have your Losartan/Hydrochlorothiazide at hand, it can give out both meds and bill them separately. To get your meds, call or visit your drugstore and mention Normative Letter 2022-0321. PSG_4038_2022_039_E

  • ASES developed a process to give you insulin after being in the hospital for emergency. The drugstore can give you this supply within 10 days after your discharge from the hospital or ER. To get it, take a recent insulin prescription to the drugstore and present your release summary from the hospital. When you call or visit your drugstore for this, mention Normative Letter 22-0303. PSG_4038_2022_040_E

  • The hormonal medications in the Vital Plan Formulary will be covered to beneficiaries without restriction due to gender (male or female). You can receive your prescribed hormone.

Send Us Your Questions or Feedback

We will answer your questions within two business days.

Incomplete Information In order to send us your consultation, you must fill out all the information required. Please, verify that the following blanks have been filled and submit the information again.

  • Full Name: This field is required to submit the information.
  • Email: This field is required to submit the information.
  • You are a: Please identify the person type, selecting the appropiate value.
  • Your question or feedback: This field is required to submit the information.

Alert

By clicking this link, you are leaving the website of Vital. If you need further assistance you may contact the Vital Call Center at 787-775-1352. (TTY users should call 1-855-295-4040).

Hours are from 7:00 a.m. to 7:00 p.m., 7 days a week.

Continue